Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
47.50    0.95 (2.04%)
Bid:
46.70
Ask:
47.50
Spread: 0.80 (1.713%)
Market Cap: £189.10m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Disposal

13 Oct 2022 07:00

RNS Number : 7074C
CLS Holdings PLC
13 October 2022
 

 

 

PRESS RELEASE

 

 

Release date: 13 October 2022 

Embargoed until: 07:00 am 

 

 

CLS Holdings plc ("CLS" or the "Group")

CLS announces the sale of Sentinel House for £7.0 million, 4.5% above valuation

 

CLS announces that it has simultaneously exchanged and completed on the sale of Sentinel House in Coulsdon, Greater London, for £7.0 million excluding costs.

 

Sentinel House was acquired by CLS in 2012 and consists of 3,211 sqm (36,711 sq. ft) of office space over 3 floors with ancillary car parking. Throughout our ownership the asset has been let on an FRI basis to IHS Global Limited which will expire at the end of 2022.

 

The sale, at a price 4.5% above the 30 June 2022 valuation, allows CLS to crystallise the returns on the asset while releasing capital to strengthen its liquid resources.

 

Fredrik Widlund, Chief Executive Officer of CLS, commented:

 

"The sale of Sentinel House is in line with CLS' asset management strategy and secures a significant return on the asset, capturing value for investors while increasing financial flexibility for the Group. The Group remains convinced of the attractions of well-located, high-quality offices in non-prime locations whilst continually assessing whether to hold or sell properties in-line with CLS' business model."

 

 

-ends-

 

For further information, please contact:

 

 

CLS Holdings plc

(LEI: 213800A357TKB2TD9U78)

www.clsholdings.com

Fredrik Widlund, Chief Executive Officer

Andrew Kirkman, Chief Financial Officer

+44 (0)20 7582 7766

 

Liberum Capital Limited

Richard Crawley

Jamie Richards

+44 (0)20 3100 2222

 

Panmure Gordon

Hugh Rich

+44 (0)20 7886 2733

 

Berenberg Matthew ArmittRichard Bootle+44 (0)20 3207 7800

Edelman Smithfield (Financial PR)

Alex Simmons 

Hastings Tarrant

+44 (0)20 3047 2546

Registered in England No. 2714781. Registered Office as above.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISFLFVRIFLFLIF
Date   Source Headline
16th Dec 20164:35 pmRNSPrice Monitoring Extension
12th Dec 201610:57 amRNSDirector/PDMR Shareholding
30th Nov 201610:24 amRNSDirector/PDMR Shareholding
23rd Nov 20167:00 amRNSTrading Statement
3rd Nov 201611:46 amRNSDirector/PDMR Shareholding
24th Oct 20164:21 pmRNSDirector/PDMR Shareholding
24th Oct 20167:00 amRNSDisposals
11th Oct 201610:26 amRNSDirector/PDMR Shareholding
28th Sep 20169:29 amRNSDirector/PDMR Shareholding
27th Sep 20165:16 pmRNSDirector/PDMR Shareholding
22nd Sep 20164:30 pmRNSCompletion of Tender Offer and Total Voting Rights
13th Sep 20163:31 pmRNSResult of Tender Offer
7th Sep 20167:00 amRNSCompletion of Düsseldorf acquisition
26th Aug 20164:48 pmRNSTender Offer
17th Aug 20167:00 amRNSHalf-year Report
11th Jul 20167:00 amRNSAcquisitions
4th Jul 20164:57 pmRNSTR-1: Notification of Major Interest in Shares
28th Jun 20165:07 pmRNSDirector/PDMR Shareholding
27th Jun 20165:27 pmRNSDirector/PDMR Shareholding
16th Jun 20164:40 pmRNSSecond Price Monitoring Extn
16th Jun 20164:35 pmRNSSecond Price Monitoring Extn
16th Jun 201612:02 pmRNSPrice Monitoring Extension
8th Jun 20165:48 pmRNSCorrection - Transaction in Own Shares & TVR
1st Jun 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
31st May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
27th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
26th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
25th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
24th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
23rd May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
20th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
18th May 20163:26 pmRNSDirectors' Details
18th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
17th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
16th May 20165:46 pmRNSCorrection: Director/PDMR Shareholding
16th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
12th May 20167:00 amRNSAnnouncement of Share Buy-Back Programme
11th May 20162:52 pmRNSDirector/PDMR Shareholding
10th May 20164:55 pmRNSDirector/PDMR Shareholding
10th May 20164:10 pmRNSDirector/PDMR Shareholding
3rd May 20164:40 pmRNSSecond Price Monitoring Extn
3rd May 20164:35 pmRNSPrice Monitoring Extension
29th Apr 20164:44 pmRNSCompletion of Tender Offer and Total Voting Rights
28th Apr 20163:44 pmRNSCorrection: Holding(s) in Company
28th Apr 20163:13 pmRNSHolding(s) in Company
28th Apr 20163:01 pmRNSDirector/PDMR Shareholding
28th Apr 20162:57 pmRNSDirector/PDMR Shareholding
20th Apr 20165:01 pmRNSResult of Tender Offer
20th Apr 20161:11 pmRNSResult of AGM
7th Apr 20163:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.